BioSpace News Archive

Press Releases

Coya Therapeutics Announces Positive Results of a Double-Blind Study of Subcutaneous Low-Dose Interleukin-2 (LD IL-2) in Alzheimer’s Disease (AD) Presented at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24) in Madrid (Spain)

October 29, 2024
·
18 min read
Press Releases

GlycoMimetics Announces National Cancer Institute Phase 2/3 Study of Uproleselan Did Not Meet Primary Endpoint

October 29, 2024
·
2 min read
Press Releases

Bitterroot Bio Completes Enrollment in Phase 1 First-in-Human Study of BRB-002 in Healthy Volunteers

October 29, 2024
·
1 min read
Press Releases

Avinger to Announce Third Quarter 2024 Results on November 7, 2024

October 29, 2024
·
1 min read
Press Releases

Aro Biotherapeutics Opens Enrollment of Phase 1b Trial of ABX1100 in Patients with Late-Onset Pompe Disease (LOPD)

October 29, 2024
·
3 min read
Press Releases

Sapio Sciences Expands Collaboration With AWS to Advance Science-Aware AI Vision

October 29, 2024
·
3 min read
Press Releases

Biodesix to Participate in Three Investor Conferences in November 2024

October 29, 2024
·
1 min read
Press Releases

Immunovant Announces Oral Presentation of Late Breaking Abstract for Phase 2 Graves’ Disease Clinical Data at the 2024 American Thyroid Association (ATA) Annual Meeting

October 29, 2024
·
1 min read
Press Releases

Castle Biosciences Presents Award-Winning Abstract at ACG 2024 Demonstrating Ability of Its TissueCypher® Test to Significantly Reduce Healthcare Costs Associated with the Management of Barrett’s Esophagus Patients

October 29, 2024
·
5 min read
Press Releases

Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases

October 29, 2024
·
5 min read